Characteristics of Patients With Thymoma in Chulalongkorn Hospital

This study has been completed.

Sponsor:

Information provided by:

Chulalongkorn University

ClinicalTrials.gov Identifier:

NCT01123590

First received: May 12, 2010

Last updated: November 21, 2010

Last verified: November 2010

History of Changes

Tracking Information

First Received Date ^ICMJE

May 12, 2010

Last Updated Date

November 21, 2010

Start Date ^ICMJE

November 2009

Primary Completion Date

April 2010 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Thymoma staging and clinical manifestations [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01123590 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

Official Title ^ICMJE

Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

Brief Summary

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

Detailed Description

To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case Control
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Retention: Samples Without DNA

Description:

PBMC

Sampling Method

Non-Probability Sample

Study Population

Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Condition ^ICMJE

Thymoma Staging
Clinical Presentations
Associated Disorders
Laboratory Findings

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Thymoma
Patients with thymoma
Control
Normal controls

Publications *

Thongprayoon C, Tantrachoti P, Phatharacharukul P, Buranapraditkun S, Klaewsongkram J. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):85-93. doi: 10.1007/s00005-012-0207-9. Epub 2012 Dec 11.

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

October 2010

Primary Completion Date

April 2010 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

None

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Thailand

Administrative Information

NCT Number ^ICMJE

NCT01123590

Other Study ID Numbers ^ICMJE

Chula-ARC 003/09

Has Data Monitoring Committee

Yes

Responsible Party

Jettanong Klaewsongkram, Chulalongkorn University

Study Sponsor ^ICMJE

Chulalongkorn University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Jettanong Klaewsongkram, MD

Chulalongkorn University

Information Provided By

Chulalongkorn University

Verification Date

November 2010

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top